Search – Page 10 – Indianapolis Business Journal

Home » Search

Articles

FDA takes aim at Hims and other telehealth services in drug advertising crackdown

September 16, 2025 | Associated Press

The Food and Drug Administration on Tuesday posted more than 100 letters to various drug and online prescribing companies, including Hims & Hers, which has built a multibillion-dollar business centered on lower-cost versions of blockbuster obesity injections.

Eli Lilly to build $5B plant in Virginia—first of 4 U.S. sites to be named this year

September 16, 2025 | Daniel Lee

Indianapolis-based Lilly said the new plant would create more than 650 jobs in Virginia for engineers, scientists, operations personnel and lab technicians, as well as 1,800 construction jobs.

Indianapolis-based ag giant Corteva considering split-up, report says

September 13, 2025 | IBJ Staff

The $50 billion company is considering dividing its seed and pesticide businesses into separate companies, the Wall Street Journal reported

Lilly rival Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs

September 10, 2025 | Associated Press

The restructuring, which would eliminate 11% of the company’s workforce, aimed to reduce organizational complexity and speed up decision-making as the company faces a more competitive market for obesity drugs.

Elanco reports pet parasite treatment quickly hit $100M blockbuster status

September 8, 2025 | Daniel Lee

The sales momentum comes as Elanco prepares to open its $200 million-plus corporate campus next month on the west side of downtown Indianapolis.

State’s exit from GM site ownership signals new economic development approach

September 5, 2025 | Mickey Shuey

“The governor has been very clear: We’re just not in the land development business, and it’s not a core competency,” Commerce Secretary David Adams told IBJ.

World Health Organization adds Mounjaro to its list of essential medicines

September 5, 2025 | Bloomberg News

The recommendation applies to a range of GLP-1 drugs that also includes Novo Nordisk’s Ozempic and Lilly’s older diabetes treatment, Trulicity.

Kia Wright: Investing in our youth is state’s economic imperative

August 29, 2025 | Kia Wright

When young people connect with leaders who share their cultural background, they gain professional skills and confidence in their ability to succeed.

Mounjaro price hike fuels UK pharmacy battle to retain customers

August 29, 2025 | Bloomberg News

Eli Lilly and Co. announced this month it would raise the weight-loss treatment’s price by as much as 170%, presenting pharmacies with a dilemma about how much they would pass on to patients.

Midwest Food Bank of Indiana unveils $9M fundraising campaign for new Indy-area warehouse

August 29, 2025 | Daniel Lee

A new 50,000-square-foot facility would help consolidate and streamline operations, the food bank said.

Lilly’s weight-loss pill moves ahead after pivotal trial

August 26, 2025 | Bloomberg News

The company’s shares rose as much as 4.3% Tuesday after Eli Lilly announced the trial results for orforglipron.

Parkview Health to build $150M hospital in Lebanon

August 26, 2025 | Daniel Lee

Parkview said work on the 108,000-square foot hospital and 30,000-square foot medical office building is expected to begin next year.

Former pharmaceutical exec’s Zionsville home hits market for $11.9M

August 25, 2025 | Mickey Shuey

The 18-acre estate features a 14,200-square-foot residence with five bedrooms and eight bathrooms, as well as a guest house.

Mitch Frazier: State must find balance to grow economy more

August 22, 2025 | Mitch Frazier

Growing Indiana’s economy should not be framed as a choice between supporting existing businesses and attracting strategically important newcomers. Both are essential.

Elanco CEO says new products helping to turn the corner on growth

August 15, 2025 | Susan Orr

Elanco Animal Health last week released what CEO Jeff Simmons called its best quarterly earnings since its 2018 spinoff from Eli Lilly and Co.

Lebanon commission to review Meta’s 15-building data center project at LEAP District

August 15, 2025 | Daniel Bradley

Documents dated Aug. 6 also include multiple renderings of the campus, which would include 12 data center buildings, three ancillary buildings and more than 400 parking spots.

Ireland’s exports to US plunge after tariff-induced surge, likely related to pharma stockpiling

August 15, 2025 | Bloomberg News

Indianapolis-based Eli Lilly and Co. has operated in Ireland since the late 1970s and has more than 3,500 employees there.

Lilly signs $1.3B deal with Boston startup for AI-assisted drug development

August 15, 2025 | Daniel Lee

Superluminal will use its AI-driven platform to discover and optimize small-molecule treatments for G protein-coupled receptors, or GPCRs, which have emerged as a key to conditions such as diabetes and obesity.

Lilly hikes obesity shot price in UK as Trump pressures drugmakers

August 14, 2025 | Bloomberg News

Trump sent letters to 17 of the world’s largest drugmakers earlier this month, including Lilly and Novo Nordisk A/S, insisting they lower what they charge Medicaid in the U.S. for existing drugs.

Texas AG: Eli Lilly and Co. offered kickbacks to providers to prescribe blockbuster drugs

August 12, 2025 | Daniel Lee

The complaint alleges the Indianapolis-based drugmaker offered illegal incentives to influence Texas providers to prescribe Lilly medications including Zepbound and Mounjaro.

« Previous 1 … 8 9 10 11 12 … 221 Next »

Search Results

4,409 results for '\"eli lilly\"'